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CCR7-dependent trafﬁcking of RORgþ ILCs
creates a unique microenvironment within
mucosal draining lymph nodes
Emma C. Mackley1, Stephanie Houston2, Clare L. Marriott1, Emily E. Halford1, Beth Lucas1, Vuk Cerovic2,
Kara J. Filbey3, Rick M. Maizels3, Matthew R. Hepworth4,5, Gregory F. Sonnenberg4,5,6, Simon Milling2
& David R. Withers1
Presentation of peptide:MHCII by RORg-expressing group 3 innate lymphoid cells (ILC3s),
which are enriched within gut tissue, is required for control of CD4 T-cell responses to
commensal bacteria. It is not known whether ILC populations migrate from their mucosal and
peripheral sites to local draining secondary lymphoid tissues. Here we demonstrate that ILC3s
reside within the interfollicular areas of mucosal draining lymph nodes, forming a distinct
microenvironment not observed in peripheral lymph nodes. By photoconverting intestinal
cells in Kaede mice we reveal constitutive trafﬁcking of ILCs from the intestine to the draining
mesenteric lymph nodes, which speciﬁcally for the LTi-like ILC3s was CCR7-dependent. Thus,
ILC populations trafﬁc to draining lymph nodes using different mechanisms.
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S
econdary lymphoid tissues, such as lymph nodes (LNs),
provide a highly organized microenvironment that pro-
motes the chance encounter of antigen-speciﬁc lymphocytes
with their cognate antigen. The system of lymphatic vessels that
connects these structures allows immune cells and antigen to
drain from sites of infection, resulting in an efﬁcient adaptive
immune response to immunological challenge. The formation of
LNs is dependent upon the correspondingly named lymphoid
tissue inducer (LTi) cell, a retinoic acid receptor-related orphan
receptor gt (RORgt)-dependent population in the embryo that
provides the critical lymphotoxin signals to developing stromal
cells1–4. LTi cells are now described among the group 3 innate
lymphoid cells (ILC3) of the ILC family5. Within adult mice, LTi-
like cells persist6,7, alongside NKp46þ ILC3s8 and colitogenic
NKp46 ILC3s (that appear distinct from LTi-like cells)9. All of
these ILC3s are thought to be the key cytokine producers within
the intestine, aiding epithelial barrier integrity through the
production of IL-22, although they may also drive intestinal
inﬂammation9. Within the gut, ILC3s are also required for
development of isolated lymphoid follicles and T-cell-
independent switching to IgA10,11. Consistent with a role in
CD4 T-cell responses, only the LTi-like cells found in the adult
express co-stimulatory molecules such as OX40L and CD30L,
associated with CD4 T-cell survival6,12 and indicating distinct
functions in the developed immune system. Furthermore, the
absence of RORg-expressing cells resulted in impaired memory
CD4 T-cell survival13. Crucially, it was recently demonstrated
that LTi-like ILC3s can present antigen in the context of major
histocompatibility complex II (MHCII)14, and this was required
for normal regulation of CD4 T-cell responses to commensal
bacteria. The mechanisms by which ILC3s regulate CD4 T-cell
responses and the site where this occurs are unknown. How, for
example, do the ILC populations in secondary lymphoid tissue
relate to those in the periphery? It is possible that speciﬁc ILC
subsets migrate to secondary lymphoid tissue in order to present
peptides, akin to dendritic cells (DCs).
To better understand this, here we investigate the ILC
composition of a range of LNs, comparing those that drain
peripheral tissues to those that drain mucosal sites. While ILCs
can be detected in all LNs analysed, RORgþ ILC3s are enriched
within mesenteric (m) and mediastinal (md) LNs, which drain
mucosal tissues. Within the mLNs, ILC3s reside exclusively
within the interfollicular spaces, where they sit within close
proximity to GATA-3þ ILC2s and form a microenvironment
that was not detected within inguinal (i), brachial (b) or popliteal
(p) LNs. Studies with Kaede transgenic mice demonstrate
constitutive trafﬁcking of ILCs from the gut to the mLN.
Migration of LTi-like ILC3s, but not other ILC subsets, is
dependent upon CCR7. Therefore, our data reveal that ILC
populations utilize different mechanisms to trafﬁc to secondary
lymphoid tissue, with mucosal-draining LNs containing a distinct
interfollicular microenvironment populated by LTi-like ILC3s.
Results
ILC3s are the main ILC group in mucosal-draining LNs. Many
studies of ILCs have focused on their role at barrier sites
of the body such as the gastrointestinal tract, the lung and the
skin9,15–20. Although ILC populations have been described within
the secondary lymphoid tissue9,12,14,17,20,21, this has often
been in mice lacking B and T cells9,12,20. Therefore, initially
we sought to analyse the ILC populations present within LNs that
drain distinct anatomical sites in wild-type (WT) mice.
Given concerns that surface markers such as Thy1 are not
deﬁnitive, we ﬁrst identiﬁed IL-7RaþLin (B220, CD3, CD5 and
CD11c) cells, and then used the expression of T-bet, GATA-3
and RORg to identify the ILC1, ILC2 and ILC3 groups,
respectively (Fig. 1a). This strategy excludes conventional
natural killer (NK) cells and focuses the analysis to the
‘helper’ ILC subsets recently shown to derive from an Id2þ
IL-7Raþ progenitor22. Intracellular staining for CD3 was
included to ensure exclusion of T cells. Per bLN or iLN,
comparable numbers of ILC1s, ILC2s and ILC3s were detected
(Fig. 1b). Notably, the number of ILC1s, ILC2s and ILC3s per
individual mLN was signiﬁcantly higher than in the peripheral-
draining LNs (Fig. 1b), and within mLNs there were signiﬁcantly
more ILC3s than any other type of ILC, notable since these nodes
drain the ILC3-enriched intestinal tissue10,16. Analysis of the ILC
composition of each LN, shown as % of the IL-7RaþLin
population, further highlighted the dominance of the ILC3
population within the mLN, although ILC3s were still present in
all the peripheral LNs assessed (Fig. 1c,d). Surprisingly, the mdLN
ILC populations were also dominated by ILC3s (Fig. 1c,d), despite
the strong association of ILC2s with the lung and the lack of
ILC3s in lung tissue16,23,24. In contrast, the proportion of ILC3s
was lowest within the pLN, a small peripheral LN (Fig. 1c,d),
revealing an ILC3 bias within mucosal tissue-draining LNs. In the
gut, ILC3s can be subdivided based on cytokine expression and
expression of the surface markers CCR6, CD4, MHCII and
NKp46 (refs 9,18,25). We found that the majority of ILC3s in the
mLN (Fig. 1e,f) were CCR6þCD4þ /MHCIIþNKp46 ,
consistent with the previously described LTi-like population26.
Although a minor population of NKp46þ ILC3s were also
detected, the CCR6CD4RORgþT-betþ population detected
in the gut25 was largely absent from WT mLNs. Within the ILC1
group, a population of ex-ILC3 cells has been described, where
expression of RORg is lost and T-bet and NKp46 expression is
turned on. Using RORg cre x ROSA26 eYFP fate mapping mice
(Supplementary Fig. 1) we found that in all LNs analysed, a
substantial population of T-betþ eYFPþRORg cells were
evident. The ability of the LN ILC3s to produce IL-22 was
conﬁrmed by in vitro culture with IL-23 (Fig. 1g), with ILC3s in
the mLN signiﬁcantly better at producing IL-22 than their
counterparts in iLNs (Fig. 1h).
Since ILC3s regulate CD4 T-cell responses to commensal
bacteria14, we sought to further assess whether ILC3s limit CD4
Figure 1 | ILC composition of mucosal LNs differs from peripheral LNs. (a) Gating strategy for detection of ILC populations by ﬂow cytometry with
T-betþ ILC1, GATA-3þ ILC2 and RORgþ ILC3. T-bet isotype control is shown in grey. Plots are representative of 10 mice from three independent
experiments. (b) Enumeration of ILC1, ILC2 and ILC3 cells per individual inguinal (i; n¼ 8), brachial (b; n¼ 12 except for ILC1 where¼ 8) or mesenteric
(m; n¼ 14 except for ILC1 where¼ 10) LNs of WTmice. Data pooled from a minimum of three independent experiments. (c) Pie charts showing the
median percentage of total Lin IL-7Raþ cells that are ILC1, ILC2 and ILC3 populations in different LNs, including also popliteal (p; n¼ 3) and mediastinal
(md; n¼ 3) LNs. Data pooled from a minimum of three independent experiments; white segment shows % cells outside transcription factor gates.
(d) Percentage of ILCs expressing RORg in different LNs (n¼ 3, 8, 12, 14, 3 mice per group), pooled from a minimum of three independent experiments.
(e) Percentage of RORgþ ILC3s expressing CCR6, CD4, MHCII and NKp46 in mLN. (f) Expression of MHCII and NKp46 by RORgþ ILC3s within the mLN.
Plots are representative of 10 mice from three independent experiments. (g) Expression of IL-22 by CD4þ RORgþ ILC3s. Plots are representative of eight
mice from three independent experiments. (h) Percentage of CD4þ and CD4 RORgþ ILC3s in mLN and iLN expressing IL-22 after culture with IL-23
(n¼8, 9). Data pooled from three independent experiments. (i) Number of 2W1S:I-Abþ CD4 Tcells per peripheral LN pool from H2-Ab1ﬂ/ﬂ andMHCIIDILC3
mice (n¼4, 4) 6 days post i.p. immunization with 2W1S peptide. Data pooled from one experiment. *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001
(Mann–Whitney non-parametric, two-tailed test). Bars represent the median values in all graphs.
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T-cell responses within LNs following immunization. Mice in
which ILC3s lack MHCII (MHCIIDILC3)14 were immunized
intraperitoneally (i.p.) with 2W1S peptide and the endogenous
CD4 T-cell response assessed in a pool of ILC3-containing
peripheral LNs. Within the peripheral LNs of MHCIIDILC3 mice
6 days post immunization, the 2W1S response was substantially
enhanced compared with controls and 2W1S-speciﬁc CD4
T cells showed increased frequencies of cells with an effector
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phenotype (CD44þCD62Llo; Fig. 1i), consistent with a regulatory
function for ILC3s in limiting CD4 T-cell responses through an
MHCII-dependent mechanism.
ILC3s form a distinct microenvironment in mucosal LNs.
Immunoﬂuorescence staining was used to assess the location of
ILC3s within LNs. Cells identiﬁed as ILC3s (RORgþ IL-7Raþ
CD3 ) (Fig. 2a,b) were located almost exclusively within the
interfollicular spaces of the mLN, with a scattering of cells further
into the T zone at the interface with the follicle (Fig. 2a,b). Besides
ILC3s, T cells expressing RORg (RORgþ IL-7RaþCD3þ ) were
identiﬁed within the interfollicular areas and T zone. To quantify
ILC3s and RORgþ T cells within the interfollicular areas, regions
between B-cell follicles were marked and the percentage of
RORgþ IL-7Raþ cells lacking CD3 calculated (Fig. 2c and
Supplementary Fig. 2). These data demonstrate that the inter-
follicular areas of the mLN are dominated by ILC3s, while in the
iLN and pLN most cells expressing RORg are T cells, consistent
with the ﬂow cytometric analysis detecting fewer ILC3s within
these tissues.
Given their distinctive location, we also investigated whether
ILCs are important for maintaining stromal cell populations within
these tissues, a role that would be analogous to ILC3 function in
the embryo. Different stromal cells were analysed in sections of LN
from bone marrow (BM) chimeras where ILC3s were heavily
depleted. No gross effects were evident in LN architecture with
normal segregation of B and T cell areas. Lymphatic vessels and
high endothelial venules appeared comparable between depleted
and control chimeras (Supplementary Fig. 3). The marginal
reticular cell population, identiﬁed by expression of RANKL and
located at the outer edge of follicles and thus in close proximity to
ILCs also appeared normal (Supplementary Fig. 3). Therefore no
overt changes in LN structure or the composition of LN stromal
populations were evident after ILC3 depletion.
The location of ILC2s within secondary lymphoid tissue has
not yet been described. To identify ILC2s within mLN sections,
expression of GATA-3 and ICOS or GATA-3 and KLRG-1
(ref. 27) were assessed. Cells lacking CD3 and expressing either
GATA-3 and KLRG-1 (ref. 27) or GATA-3 and ICOS17 were
identiﬁed within the interfollicular spaces alongside ILC3s
(Fig. 2d). Although fewer in number (Fig. 1b), this suggests
that both ILC2s and ILC3s reside within close proximity within
a LN.
Given that T cells expressing RORg reside in similar areas in
the LN to ILC3s, we also sought to understand the contribution
that ILC3s make to the total RORgþ population (Supplementary
Fig. 4). Gating on RORgþB220CD11bCD11c cells, we
found that ILC3s constituted a very minor (o5%) proportion of
RORgþ cells in peripheral LNs; however, a signiﬁcantly larger
part of the RORgþ population in mLNs (420%). Collectively,
our data reveal that ILC3s are more numerous in LNs draining
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Figure 2 | ILC2 and ILC3 cells reside within the interfollicular spaces. (a) Tilescanned images of murine mLN and iLN stained for expression of RORg,
CD3 and IL-7Ra, counterstained with DAPI. (b) Magniﬁed image showing interfollicular area of mLN, stained for expression of RORg, CD3 and IL-7Ra,
counterstained with DAPI. Small panels show numerous RORgþCD3 IL-7Raþ cells. (c) Quantitation of RORg-expressing cells within the interfollicular
areas of different LNs, showing percentage of RORgþ cells lacking CD3 expression (n¼6, 6, 6, 4 areas from three WTmice). *Po0.05, **Po0.01 (Mann–
Whitney non-parametric, two-tailed test) bars represent the median values. (d) Serial sections of mLN showing the same interfollicular area stained for
ILC3s (RORgþCD3 IL-7Raþ ) and ILC2s (GATA-3þCD3KLRG-1þ or GATA-3þCD3 ICOSþ ). Scale bar in all images represents 100 mm. Data
representative of at least three WTmice per stain per tissue.
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mucosal tissue, and that they form a distinct microenvironment
within the interfollicular spaces.
Altered ILC frequencies in lymphopenic mice. Studies of ILC3
function have often relied upon Rag / mice and anti-Thy1
antibody (Ab) treatment to deplete these cells in vivo9,20. To enable
comparison of our data with previously published studies, we
sought to assess the ILC composition of LNs in Rag / mice
using the ﬂow cytometric analysis described above (Fig. 3a).
Surprisingly, within the mLN, this differed vastly from that of WT
mice, with GATA-3þ ILC2s replacing RORgþ ILCs as the
dominant population (Fig. 3a–c). Furthermore, this difference was
mLN-speciﬁc, since within iLNs a comparable percentage of each
ILC type was detected (Fig. 3d,e). The majority of the ILC3s in
Rag / mLNs lacked CCR6 and CD4 expression (Fig. 3f,g), thus
resembling a distinct population described within the intestine25,
which is not detected in WT mLN (Fig. 1e,f). Given the disrupted
architecture within Rag / LNs, mLNs from other T-cell-
deﬁcient mice were also assessed with similar results (Fig. 3g–k).
Therefore, the composition of ILCs within the gut-draining mLN is
altered in T-cell-deﬁcient mice highlighting the importance of
using WT mice. In addition, the high frequency of ILC2 cells
within T-cell-deﬁcient mLNs enabled us to conﬁrm our previous
location studies. Within ZAP70 / mLN, as in WT, ILC2s were
readily detected within the interfollicular spaces and at the B:T
interface, interspersed with the ILC3s (Supplementary Fig. 5).
ILCs trafﬁc from the gut to the mLN. Since ILC3s are con-
centrated within the gut, we sought to test whether an ILC3 bias
in the mLN reﬂected direct trafﬁcking of ILC3s from the intestine
to the mLN using transgenic Kaede mice28. Here cells express the
photoconvertible Kaede protein that converts irreversibly from
green to red ﬂuorescence following violet light exposure.
Following laparotomy via a small midline incision, the small
intestines of Kaede mice were carefully exposed to violet light
(labelled ‘photoconverted’, or PC), while the mLN and Peyer’s
patches (PPs) were shielded, thus speciﬁcally labelling intestinal
cells. In all experiments with Kaedemice, expression of Kaede-red
protein was based upon comparison with ambient light-treated
surgery control mice (labelled ‘non-converted’ or NC). In PC
mice immediately after surgery, ILCs (Fig. 4a,d) and CD4 T cells
(Fig. 4b,e) in the small intestine expressed Kaede-red protein
compared with NC controls. ILCs within the shielded mLN were
not labelled by this process (Fig. 4c). Analysis of the mLNB24 h
after exposure of the intestine to violet light revealed a signiﬁcant
number of Kaede-redþ ILCs within this site (Fig. 4f)
demonstrating the direct trafﬁcking of these cells from the
intestine to the mLN. Gating speciﬁcally on the CCR6þ ILC3s
and CCR6Sca-1þ putative ILC2s revealed that both
populations had migrated from the intestine (Fig. 4f). While
only a modest proportion of CD4 T cells in the mLN of PC mice
at 24 h expressed Kaede-red protein (Fig. 4g), substantially more
of the ILCs were labelled (Fig. 4h) and this was true of both the
ILC3 and ILC2 subsets (Fig. 4i,j). Within the iLN at 24 h post
surgery, very few ILCs or T cells expressing Kaede-red were
detected (Fig. 4k,l). These data demonstrate that ILC populations
in the gut are able to trafﬁc to the draining mLN.
LTi-like ILC3s require CCR7 to trafﬁc to LNs. Homing of
lymphocytes and DCs to LNs requires CCR7 (ref. 29), and both
embryonic LTi cells and adult splenic LTi-like cells express CXCR5
and CCR7 mRNA26,30; therefore, we hypothesized that CCR7 was
required for trafﬁcking of ILC3s into LNs. In CCR7 /
mice, the total numbers of LTi-like ILC3s were signiﬁcantly
reduced in both mLNs and iLNs compared with WT tissues
(Fig. 5a and Supplementary Fig. 6). Notably, total numbers of
NKp46þ ILC3s, as well as both ILC1 and ILC2 populations, were
not signiﬁcantly different in mLNs. Furthermore, no signiﬁcant
difference in the number of LTi-like ILC3s was detected in WT
and CCR7 / spleens, indicating that the difference in LNs was
not simply due to a systemic reduction in LTi-like ILC3s in
CCR7 / mice (Fig. 5a). To investigate whether LN entry of LTi-
like ILC3s was dependent upon direct signalling through CCR7,
mixed BM chimeras were generated using an B1:1 mix of either
WT (CD45.1):WT (CD45.2) or WT (CD45.1):CCR7 /
(CD45.2) BM (Fig. 5b,c and Supplementary Fig. 7). The use of
CD45.1þ CD45.2þ host mice enabled any residual host cells
within these chimeras to be identiﬁed and excluded from the
analysis, thus removing any possible bias from the persistence of
radio-resistant host cells. Consistent with a dependency on CCR7
for CD4 T-cell entry into LNs29, in WT:CCR7 / chimeras,
B90% of the LN CD4 T cells were of WT BM origin. This bias
was not seen in the WT:WT BM chimeras, validating the mixed
BM chimera approach. The vast majority of LTi-like ILC3s in the
LNs of WT:CCR7 / BM chimeras were derived from WT BM,
while this was not the case for ILC2s in LNs (Fig. 5b). The homing
of both CCR7 / CD4 T cells and LTi-like ILC3s to the spleen
was much less impaired than in LNs, as CCR7 is not critical for
entry to this tissue (Fig. 5c). To further test whether ILC3s were
functionally sensitive to CCR7 ligands, a transmigration assay
using WT mLN cells was performed. ILC3s, but not ILC2s,
migrated towards CCL21, albeit less efﬁciently than CD4 T cells or
DCs (Fig. 5d), consistent with functional CCR7 expression. In
summary, LTi-like ILC3s, but not other ILC subsets, require CCR7
to enter LNs.
Accumulation of LTi-like ILC3s post infection requires CCR7.
Our studies using the Kaede mice demonstrated that ILCs, par-
ticularly the ILC3s, were able to trafﬁc from the intestine to the
mLN, but we sought to further investigate ILC trafﬁcking using
an alternative system. To this end, we used an infection model
with the natural mouse parasite Heligmosomoides polygyrus.
Following oral gavage with infective larvae, the helminths pene-
trate the submucosae of the small intestine, eliciting a strong Th2
response in the draining mLN. Control of this infection involves
both innate and adaptive responses with accumulation of ILC2
cells previously reported31,32. It was also recently shown that
H. polygyrus infection can induce IL-1b production33, dampening
IL-25 and IL-33 responses and aiding pathogen chronicity, while
within the lung IL-1b signals cause expansion of ILC3s34.
Consistent with previous studies, in BALB/c mice, where the
infection is cleared, we observed a signiﬁcant increase in ILC2s in
the mLN 7 days post infection (dpi; Fig. 6a)31,32. In contrast,
within C57BL/6 mice, which fail to clear the infection, no
signiﬁcant accumulation of ILC2 was observed by 7 dpi, although
by 14 dpi numbers appeared more comparable to infected BALB/
c mice, again consistent with previous observations31. Strikingly,
in both strains of mice there was also a signiﬁcant increase in the
number of ILC3s within the mLN after infection, likely reﬂecting
IL-1b production and/or intestinal damage caused by the parasite
(Fig. 6a). To investigate whether ILC accumulation in the mLN
reﬂected trafﬁcking or in situ proliferation, expression of Ki-67
was assessed (Fig. 6b,c). Among ILC populations in the mLN,
there was no evidence of proliferation by the LTi-like ILC3s in
control or infected mice, while both NKp46þ ILC3s and ILC2s
showed evidence of increased Ki67 expression after H. polygyrus
infection, therefore, indicating that ILC3 accumulation in the
mLN after H. polygyrus infection reﬂects trafﬁcking of cells from
the intestine. This accumulation was dependent upon CCR7, as
numbers of ILC3, but not ILC1 or ILC2 populations remained
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signiﬁcantly reduced in CCR7 / mLNs 7 dpi compared with
C57BL/6 WT (Fig. 6d). Furthermore, this reduction was speciﬁc
to the LTi-like ILC3 population, since there was no signiﬁcant
difference in the number of NKp46þ ILC3s in WT versus
CCR7 / mLN at 7 dpi (Fig. 6e). Surprisingly, analysis of Ki-67
expression revealed that in the absence of CCR7, proliferation of
both the LTi-like and NKp46þ ILC3 populations was
substantially increased after infection (Fig. 6f,g), indicating
dysregulation of the normal response to this parasite. In
summary, these data show that accumulation speciﬁcally of
LTi-like ILC3s in the draining mLN is dependent upon CCR7.
Discussion
Here we demonstrate that the interfollicular areas of mucosal
draining LNs contain a microenvironment populated by
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numerous LTi-like ILC3s. Using Kaede mice we show that ILC3s
are able to trafﬁc to the draining mLN. We report that in the
absence of cell-intrinsic CCR7 signalling, the LTi-like ILC3
subset, which forms the majority of ILC3s in LNs, is signiﬁcantly
reduced. In vitro, ILC3s are able to migrate towards a ligand of
CCR7, CCL21. Finally, using a helminth infection model we show
that accumulation of LTi-like ILC3s in the draining LN requires
CCR7 expression.
Although a rare population within secondary lymphoid tissue,
concentrated clusters of ILC3s can be found within interfollicular
areas of LNs. This region is a key site for interactions during the
initial stages of adaptive responses, with both antigen-speciﬁc
CD4 T and B cells speciﬁcally located here before migration into
the follicle35. Given their expression of MHCII, but a lack of
CD80 and CD86 (ref. 14), ILC3s are unlikely to drive T-cell
proliferation under homeostatic conditions. Rather, these cells
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likely interact with effector cells after priming, regulatory T cells
or memory CD4 T cells recirculating through the tissue. While
many more ILC3s were detected within the interfollicular areas of
the mLN compared with peripheral LNs, antigen-speciﬁc CD4 T
cells were increased in the peripheral LNs of MHCIIDILC3 mice
after peptide immunization, indicating that ILC3s function in a
regulatory manner within these tissues as well as within the gut
and mLN14. Integration of innate stimulatory signals induced by
adjuvants or infectious agents may shape the outcome of
ILC3:CD4 T-cell interactions36, perhaps through inducing
expression of co-stimulatory molecules.
While we know that ILC3s are concentrated in the intestine,
and now the mLN, the relationship between the populations at
these sites was unclear. Our observation that photoconverted
ILC3s within the gut of Kaede mice can readily trafﬁc from the
intestine to the draining mLN leads us to question where does
ILC3-mediated control of CD4 T-cell responses to commensal
bacteria14 actually occur in vivo? Is antigen transferred to ILC3
within the mLN from other migrating cells, or could ILC3
potentially acquire antigen in the gut and trafﬁc directly to the
mLN? Given both their ability to migrate and their location in
LNs, it is possible to propose a model where these cells acquire
commensal antigens in the gut and present it to responding CD4
T cells within interfollicular areas. Although deletion of MHCII
on ILC3s did not affect their frequency in the mLN14, it is not
clear whether antigen uptake is required for trafﬁcking from the
gut. Further understanding of the speciﬁc role of co-stimulatory
molecules by ILCs, and whether or not these change following
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immunization, is required to really understand how these cells
might regulate CD4 T cells.
A surprising discovery from the phenotyping of LN ILCs was
that a high proportion of ILCs in the mdLN were ILC3s, which,
along with the mLN, appears to distinguish it from peripheral
LNs, although ILC3s were still found here and also regulated CD4
T-cell numbers. In contrast to the gut, however, there is little
evidence of many ILC3s within the lung16, arguing against
trafﬁcking from this site to the mdLN, perhaps pointing
instead to a role in regulating responses to bacterial antigens
from the lower respiratory tract. In all LNs analysed, however, it
appears that the number of ILC3s is highly CCR7-dependent.
This would suggest a common mechanism by which these cells
enter LNs, likely through the afferent lymphatics, a CCR7-
dependent process based upon comparisons with T cells37.
It remains possible that ILCs may enter LNs from the circulation
through high endothelial venules in a CCR7-dependent
manner, however, ILC3s are largely CD62L 4. Progenitor
populations have been described in the BM and blood22,27;
however, it is not clear that ‘mature’ ILC populations exist in the
circulation. Furthermore, we cannot rule out the possibility that
the observed reduction in numbers of LTi-like ILC3 in CCR7 /
LNs does not, to some extent, result from the additional
absence of T cells in these tissues. The partial rescue of CCR7-
deﬁcient ILC3 numbers in the mesenteric, but not inguinal, LNs
of mixed BM chimeras is suggestive of some cell-extrinsic effects
in this tissue, which may be especially relevant, given our
observation of vastly reduced numbers of ILC3 speciﬁcally in the
mLN of T-cell-deﬁcient mice. Our data also show that different
ILC populations utilize distinct homing receptors for migration.
Even among the ILC3s, those expressing NKp46 showed no clear
requirement for CCR7 in reaching the mLN, an observation that
also applies to ILC2s. On the basis of expression of Ki-67, ILC2s
appear more proliferative than ILC3s, and it seems likely that
changes in the number of ILC2s reﬂect a combination of
proliferation and trafﬁcking, with data from the Kaede mice
showing that they are capable of migrating from the intestine to
the mLN. It is possible that activation through IL-33 or thymic
stromal lymphopoietin (TSLP)19,38 may be driving migration to
the draining LN, with a reliance on alternative chemokine
receptors to CCR7.
While the effects of ILC populations on B-cell responses in LNs
have not been explored, ILC3s do support T-independent
switching to IgA within isolated lymphoid follicles11, and it was
recently shown that within the spleen, marginal zone B-cell
responses are inﬂuenced by ILC3s39. It is noteworthy in this latter
study that the phenotype of the human splenic ILC3 population
described was distinct (CD40LþNKp46þ ) from the majority of
those ILC3s detected in mouse secondary lymphoid tissue. It is
also worth noting that DCs migrate through the interfollicular
space after arrival in the afferent lymphatics40; thus, indirect
effects on the adaptive response via effects on DCs may also occur
and ILC2s have recently been shown to inﬂuence DC migration
from the lung to the LN41. Previous studies with lymphopenic
mice have provided valuable insight into what ILCs can do;
however, the challenge now is to understand their roles and
contribution within a complete immune system. Since both ILC2
and ILC3 populations share a similar location within LNs and can
process and present antigen14,42,43, one can speculate that a
balance between different ILC populations may help to shape the
outcome of adaptive immune responses. Evidence presented here
and in several recent papers indicates that ILC3s play important
roles in the control of adaptive immune responses. It will be
important to understand exactly how ILCs can inﬂuence CD4 T
cells and whether we can target this population to enhance or
restrict responses.
Methods
Mice. Animals were used in accordance with the Home Ofﬁce guidelines at the
University of Birmingham and the University of Glasgow. The following mice were
bred and maintained in the Biomedical Services Unit at the University of Bir-
mingham: Balb/c, C57BL/6, CCR7 / , Rag / , TCRa / , ZAP70 / (all
C57BL/6 background). Kaede mice were bred and maintained at the University of
Glasgow. For all these experiments, a mixture of male and female mice was used at
6–12 weeks of age. H2-Ab1ﬂ/ﬂ and MHCIIDILC3 mice (all female, aged 8 weeks) were
previously described14. Genetically modiﬁed mouse strains were compared with WT
controls from the same facility, while WT mice used in Fig. 1 were obtained from
Harlan Laboratories, all female 6–10 weeks of age. Mixed BM chimeras were
generated through intravenous transfer of an approximate 1:1 mix of CD45.1þ
WT and either CD45.2þ WT or CCR7 / BM into lethally irradiated CD45.1þ
CD45.2þ WT hosts (2 600 rad). RORg /þ hosts were lethally irradiated (2 450
rad) before intravenous transfer of WT or RORg /BM. After B4 weeks,
RORg / into RORg /þ chimeras were additionally treated with anti-Thy1 Abs
and then assessed a further 4 weeks later. Control (WT into RORg /þ ) chimeras
were treated with control rat IgG (Sigma-Aldrich).
Mice were infected with B200 L3 larvae of H. polygyrus larvae by oral gavage.
Mice were immunized i.p. with 100 mg 2W1S peptide on D0 and D2, and then
taken 6 days later. A pool of peripheral (auxillary, brachial, cervical and inguinal)
LNs were compared. WT or RORg / into RORg /þ chimeras were immunized
in the front paw pads with 2 106 ActA-deﬁcient L. monocytogenes-expressing
2W1S peptide (Lm-2W1S). Bacteria were grown overnight in a shaking 37 C
incubator in Luria–Bertani broth supplemented with 20 mgml 1 chloramphenicol,
and then subcultured and grown under the same conditions until the OD600¼ 0.1.
Bacteria were diluted in PBS for injection.
Surgical procedures. Under anaesthesia, the small intestine of Kaede transgenic
mice was exposed following laparotomy with a small midline incision. Two- to
three-centimetre sections of tissue were exposed to violet light (395 nm UV LED)
for 2–3min each, while PPs and mLN were protected from exposure using high-
density black card. Following replacement of the small intestine, the muscle layer
was sutured and the skin closed with surgical clips. Zero-hour controls were taken
immediately, while mice in 24-h time point were allowed to recover. The small
intestine of control mice was exposed to ambient light. Before surgery, the mice
received subcutaneous analgesics Carprofen (Rimadyl, Pﬁzer) and Buprenorphine
(Vetergesic, Reckitt Benckiser Healthcare) at 0.1ml and 0.15ml per 100 g,
respectively.
Cell culture. Cells were cultured overnight in RPMI/10% FCS with 10 ng
recombinant mouse IL-23, and then Brefeldin A was added to a ﬁnal concentration
of 10mgml 1 for B4 h before intracellular cytokine staining.
Flow cytometry. LNs were teased using ﬁne forceps and digested for 25min at
37 C in RPMI with 250mgml 1 Collagenase-Dispase (Roche) and 25 mgml 1
DNase I before the reaction was stopped with 10mM EDTA. Digested tissue was
then crushed through a 70-mm nylon mesh. Individual mLN numbers were
generated by dividing the total cell count by ﬁve to account for multiple nodes.
Small intestine tissue was cut longitudinally into 0.5-cm sections following the
removal of PPs and fat and washed in Hanks’ Balanced Salt Solution (HBSS, Gibco)
with 2% FCS. Tissue was incubated twice in HBSS with 2mM EDTA at 37 C for
20min in a shaking incubator, and then digested in complete RPMI with
1mgml 1 Collagenase VIII (Sigma-Aldrich) at 37 C forB15min, or until tissue
was fully digested. Cells were passed through 100 and 40 mm cell strainers. Samples
in Kaede mouse experiments were stained with an eFluor 780 viability dye in PBS
(1:1,000, eBioscience) for 30min at 4 C before antibody staining. Staining for
2W1S-speciﬁc CD4 T cells was conducted using a phycoerythrin (PE)-conjugated
2W1S:I-Ab tetramer for 1 h at room temperature, followed by enrichment using
anti-PE MicroBeads and MACS enrichment (Miltenyi Biotech)13. Antibody
staining was performed at þ 4 C for 30min unless otherwise stated. Antibodies
raised against the following mouse antigens were used: B220 (clone RA3-6B2, 1:300
or 1:100, eBioscience), CCR6 (clone 29-2L17, 1:100 or 1:25 Biolegend), CD3 (clone
145-2C11, 1:100, eBioscience), CD4 (clone RM4-5, 1:200, Biolegend), CD5 (clone
53-7.3, 1:100, eBioscience), CD11b (clone M1/70, 1:300 or 1:100, eBioscience),
CD11c (clone N418, 1:300 or 1:100, eBioscience), CD45 (clone 30-F11, 1:100,
eBioscience), CD45.1 (clone A20, 1:100, eBioscience), CD45.2 (clone 104, 1:100,
eBioscience), GATA-3 (clone TWAJ, 1:50, eBioscience), I-Ab (clone M5/114.15.2,
1:500, Biolegend), IL-7Ra (clone A7R34, 1:100, Biolegend, eBioscience), IL-22
(clone 1H8PWSR, 1:50, eBioscience), Ki-67 (clone SolA15, 1:400, eBioscience),
NKp46 (clone 29A1.4, 1:100, eBioscience), RORg (clone AFKJS-9, 1:25, 1:50,
eBioscience), Sca-1 (clone D7, 1:200, eBioscience), T-bet (clone eBio4B10, 1:25,
eBioscience). The lineage dump channel contained antibodies against B220, CD3,
CD5, CD11b and CD11c, except in Figs 1a–e and 4 and Supplementary Figure 1,
where CD11b was not included. Intracellular staining was carried out using the
FoxP3 ﬁxation and permeabilization kit (eBioscience), or in cases where it was
necessary to preserve YFP using Cytoﬁx/Cytoperm Plus (BD Biosciences), both
according to the manufacturer’s instructions. Addition of Spherotech Accucount
blank particles was used to calculate cell frequencies. Flow cytometry was
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6862
10 NATURE COMMUNICATIONS | 6:5862 |DOI: 10.1038/ncomms6862 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
performed on a Fortessa or LSR II analyzer using the FACSDiva6.2 software (BD
Biosciences), with data subsequently analysed with the FlowJo software (Tree Star).
Transmigration assay. In all, 2 106 cells (WT or CCR7 / mLN) in 100 ml
RPMI 2% FBS were loaded into transwell inserts with a diameter of 6.5mm and
pore size of 5 mm (Corning Transwell Permeable Supports, 3421, Sigma-Aldrich)
and placed in wells containing±20 nM CCL21 in RPMI with 2% FBS. Plates were
incubated for 3 h at 37 C, and then 5.5mM EDTA was added to bottom well and
plate left on ice for 10min, before migrated and input cells were analysed by ﬂow
cytometry. Percentages of migrated cells shown are as a proportion of the total
number of cells retrieved from migrated and input wells. All samples were analysed
in triplicate in each experiment, with the exception of CCR7 / controls, which
were analysed in duplicate, and average values displayed.
Immunoﬂuorescence and image analysis. Tissue sections from experimental
mice were cut and stained as described previously13,44. Brieﬂy, 6-mm-thick sections
of tissue were cut, ﬁxed in cold acetone at 4 C for 20min and then stored at  20 C
before staining. Antibodies raised against the following mouse antigens were used:
CD3 (clone eBio500A2, 1:50, eBioscience), CD31 (clone 390, 1:200, eBioscience),
CD169 (clone 3D6.112, 1:800, AbD Serotec), F4/80 (clone BM8, 1:50, eBioscience),
GATA-3 (clone TWAJ, 1:25, eBioscience), ICOS (clone C398.4A, 1:25, Biolegend),
IgM (1:200, Jackson ImmunoResearch), IL-7Ra (clone A7R34, 1:25, eBioscience),
KLRG-1 (clone 2F1, 1:50, eBioscience), RANKL (clone IK22/5, 1:50, eBioscience)
and RORg (clone AFKJS-9, 1:30, eBioscience). Detection of RORg and GATA-3
expression required ampliﬁcation of the signal as described previously44. Puriﬁed rat
primary antibodies against the transcription factors were detected with donkey anti-
rat-IgG-FITC (1:150, Jackson ImmunoResearch), and then rabbit anti-FITC-AF488
(1:200, Life Technologies) and then with donkey anti-rabbit-IgG-AF488 (1:200, Life
Technologies). Biotinylated anti-CD3 antibodies were detected with SA-AF555
(1:500, Life Technologies). Sections were counterstained with DAPI (Invitrogen) and
mounted using ProLong Gold (Invitrogen). Slides were analysed on a Zeiss 780 Zen
microscope (Zeiss). Percentage of RORgþ ILCs in interfollicular areas was
quantiﬁed using the Zen software (Zeiss).
Statistics. Data were analysed using the GraphPad Prism (versions 5.01 and 6.04).
Sample sizes of atleast four data points were used where possible. Samples were
only excluded from analysis where total cell yield isolated from tissue was greatly
reduced because of technical error. Non-parametric Mann–Whitney test was used
to determine signiﬁcance, which was set at P¼o0.05. The median values were
calculated and used in all analyses.
References
1. Eberl, G. et al. An essential function for the nuclear receptor RORgamma(t) in
the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64–73
(2004).
2. Mebius, R. E. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3,
292–303 (2003).
3. Eberl, G. & Littman, D. R. The role of the nuclear hormone receptor
RORgammat in the development of lymph nodes and Peyer’s patches.
Immunol. Rev. 195, 81–90 (2003).
4. Mebius, R. E., Rennert, P. & Weissman, I. L. Developing lymph nodes collect
CD4þCD3- LTbetaþ cells that can differentiate to APC, NK cells, and
follicular cells but not T or B cells. Immunity 7, 493–504 (1997).
5. Spits, H. et al. Innate lymphoid cells--a proposal for uniform nomenclature.
Nat. Rev. Immunol. 13, 145–149 (2013).
6. Kim, M. Y. et al. CD4(þ )CD3( ) accessory cells costimulate primed CD4 T
cells through OX40 and CD30 at sites where T cells collaborate with B cells.
Immunity 18, 643–654 (2003).
7. Takatori, H. et al. Lymphoid tissue inducer-like cells are an innate source
of IL-17 and IL-22. J. Exp. Med. 206, 35–41 (2009).
8. Sawa, S. et al. RORgammatþ innate lymphoid cells regulate intestinal
homeostasis by integrating negative signals from the symbiotic microbiota. Nat.
Immunol. 12, 320–326 (2011).
9. Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent
innate intestinal pathology. Nature 464, 1371–1375 (2010).
10. Bouskra, D. et al. Lymphoid tissue genesis induced by commensals through
NOD1 regulates intestinal homeostasis. Nature 456, 507–510 (2008).
11. Tsuji, M. et al. Requirement for lymphoid tissue-inducer cells in isolated follicle
formation and T cell-independent immunoglobulin A generation in the gut.
Immunity 29, 261–271 (2008).
12. Kim, M.-Y. et al. OX40-ligand and CD30-ligand are expressed on adult
but not neonatal CD4þCD3- inducer cells: evidence that IL7 signals regulate
CD30-ligand but not OX40-ligand expression. J. Immunol. 174, 6686–6691
(2005).
13. Withers, D. R. et al. Cutting edge: lymphoid tissue inducer cells maintain
memory CD4 T cells within secondary lymphoid tissue. J. Immunol. 189,
2094–2098 (2012).
14. Hepworth, M. R. et al. Innate lymphoid cells regulate CD4þ T-cell responses
to intestinal commensal bacteria. Nature 498, 113–117 (2013).
15. Walker, J. A., Barlow, J. L. & McKenzie, A. N. Innate lymphoid cells--how did
we miss them? Nat. Rev. Immunol. 13, 75–87 (2013).
16. Spencer, S. P. et al. Adaptation of innate lymphoid cells to a
micronutrient deﬁciency promotes type 2 barrier immunity. Science 343,
432–437 (2014).
17. Neill, D. R. et al. Nuocytes represent a new innate effector leukocyte that
mediates type-2 immunity. Nature 464, 1367–1370 (2010).
18. Satoh-Takayama, N. et al. IL-7 and IL-15 independently program the
differentiation of intestinal CD3-NKp46þ cell subsets from Id2-dependent
precursors. J. Exp. Med. 207, 273–280 (2010).
19. Kim, B. S. et al. TSLP elicits IL-33-independent innate lymphoid
cell responses to promote skin inﬂammation. Sci. Transl. Med. 5, 170ra116
(2013).
20. Sonnenberg, G. F. et al. Innate lymphoid cells promote anatomical
containment of lymphoid-resident commensal bacteria. Science 336, 1321–1325
(2012).
21. Yagi, R. et al. The transcription factor GATA3 is critical for the development of
All IL-7Ralpha-expressing innate lymphoid cells. Immunity 40, 378–388
(2014).
22. Klose, C. S. et al. Differentiation of type 1 ILCs from a common
progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340–356
(2014).
23. Nussbaum, J. C. et al. Type 2 innate lymphoid cells control eosinophil
homeostasis. Nature 502, 245–248 (2013).
24. Scanlon, S. T. & McKenzie, A. N. Type 2 innate lymphoid cells: new players in
asthma and allergy. Curr. Opin. Immunol. 24, 707–712 (2012).
25. Klose, C. S. et al. A T-bet gradient controls the fate and function of CCR6-
RORgammatþ innate lymphoid cells. Nature 494, 261–265 (2013).
26. Kim, M. Y. et al. Heterogeneity of lymphoid tissue inducer cell populations
present in embryonic and adult mouse lymphoid tissues. Immunology 124,
166–174 (2008).
27. Hoyler, T. et al. The transcription factor GATA-3 controls cell fate
and maintenance of type 2 innate lymphoid cells. Immunity 37, 634–648
(2012).
28. Morton, A. M. et al. Endoscopic photoconversion reveals unexpectedly broad
leukocyte trafﬁcking to and from the gut. Proc. Natl Acad. Sci. USA 111, 6696–
6701 (2014).
29. Forster, R., Davalos-Misslitz, A. C. & Rot, A. CCR7 and its ligands: balancing
immunity and tolerance. Nat. Rev. Immunol. 8, 362–371 (2008).
30. Finke, D. Fate and function of lymphoid tissue inducer cells. Curr. Opin.
Immunol. 17, 144–150 (2005).
31. Filbey, K. J. et al. Innate and adaptive type 2 immune cell responses in
genetically controlled resistance to intestinal helminth infection. Immunol. Cell
Biol. 92, 436–448 (2014).
32. Hepworth, M. R., Maurer, M. & Hartmann, S. Regulation of type 2 immunity to
helminths by mast cells. Gut Microbes 3, 476–481 (2012).
33. Zaiss, M. M. et al. IL-1beta suppresses innate IL-25 and IL-33 production and
maintains helminth chronicity. PLoS Pathog. 9, e1003531 (2013).
34. Kim, H. Y. et al. Interleukin-17-producing innate lymphoid cells and the
NLRP3 inﬂammasome facilitate obesity-associated airway hyperreactivity. Nat.
Med. 20, 54–61 (2014).
35. Kerfoot, S. M. et al. Germinal center B cell and T follicular helper
cell development initiates in the interfollicular zone. Immunity 34, 947–960
(2011).
36. von Burg, N. et al. Activated group 3 innate lymphoid cells promote
T-cell-mediated immune responses. Proc. Natl Acad. Sci. USA 111,
12835–12840 (2014).
37. Bromley, S. K., Thomas, S. Y. & Luster, A. D. Chemokine receptor CCR7 guides
T cell exit from peripheral tissues and entry into afferent lymphatics. Nat.
Immunol. 6, 895–901 (2005).
38. Fernandez, M. I. et al. The human cytokine TSLP triggers a cell-autonomous
dendritic cell migration in conﬁned environments. Blood 118, 3862–3869
(2011).
39. Magri, G. et al. Innate lymphoid cells integrate stromal and immunological
signals to enhance antibody production by splenic marginal zone B cells. Nat.
Immunol. 15, 354–364 (2014).
40. Braun, A. et al. Afferent lymph-derived T cells and DCs use different
chemokine receptor CCR7-dependent routes for entry into the lymph node and
intranodal migration. Nat. Immunol. 12, 879–887 (2011).
41. Halim, T. Y. et al. Group 2 innate lymphoid cells are critical for the initiation of
adaptive T helper 2 cell-mediated allergic lung inﬂammation. Immunity 40,
425–435 (2014).
42. Oliphant, C. J. et al. MHCII-mediated dialog between group 2 innate lymphoid
cells and CD4(þ ) T cells potentiates type 2 immunity and promotes parasitic
helminth expulsion. Immunity 41, 283–295 (2014).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6862 ARTICLE
NATURE COMMUNICATIONS | 6:5862 | DOI: 10.1038/ncomms6862 | www.nature.com/naturecommunications 11
& 2015 Macmillan Publishers Limited. All rights reserved.
43. Mirchandani, A. S. et al. Type 2 innate lymphoid cells drive CD4þ Th2 cell
responses. J. Immunol. 192, 2442–2448 (2014).
44. Kim, S. et al. CD117(þ ) CD3( ) CD56( ) OX40Lhigh cells express IL-22
and display an LTi phenotype in human secondary lymphoid tissues. Eur. J.
Immunol. 41, 1563–1572 (2011).
Acknowledgements
The following tetramer was obtained through the NIH Tetramer Facility: 2W1S:I-Ab.
The 2W1S:I-Ab tetramer was also generated by the Protein Expression Facility,
University of Birmingham after the kind provision of 2W1S:I-Ab producing S2 cells by
Dr Marc Jenkins. We thank Dr Fiona McConnell for help with confocal microscopy
and are grateful to Dr Andrew McKenzie for critical reading of the manuscript. This
work is funded by a Wellcome Trust Research Career Development Fellowship to
D. Withers; S. Milling and V. Cerovic are funded by the MRC (MR/K021095/1); K. Filbey
by an MRC CASE studentship together with UCB Celltech; R. Maizels by the Wellcome
Trust; G. Sonnenberg by the US National Institutes of Health (DP5OD012116); M.
Hepworth by a research fellowship from the Crohn’s and Colitis Foundation of America
(CCFA, no. 297365).
Author contributions
E.C.M. designed, performed and analysed experiments and wrote the paper; S.H.
designed, performed and analysed experiments, C.L.M. performed experiments, E.E.H.
performed experiments, B.L. designed experiments, V.C. performed experiments, K.J.F.
provided reagents for experiments, R.R.M. provided reagents, designed experiments and
wrote the paper; M.R.H. performed experiments and analysed data; G.F.S. designed
experiments and wrote the paper; S.M. designed experiments, analysed data and wrote
the paper; D.R.W. designed, performed and analysed experiments and wrote the paper.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Mackley, E. C. et al. CCR7-dependent trafﬁcking of RORgþ
ILCs creates a unique microenvironment within mucosal draining lymph nodes.
Nat. Commun. 6:5862 doi: 10.1038/ncomms6862 (2015).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6862
12 NATURE COMMUNICATIONS | 6:5862 |DOI: 10.1038/ncomms6862 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
